BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It?     2/23/2015
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center     2/18/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills     1/30/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD)     1/20/2015
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact     12/29/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada     12/9/2014
Results Of City of Hope Clinical Trial Supports Change To Standard Of Care For HIV Lymphoma     12/5/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
AbbVie (ABBV) Adds Children's AIDS Drugs To Shared Patent Pool     12/1/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights     12/1/2014
 Featured Stories
Dirty Needles Spread HIV In Indiana As Pain Pills Injected     3/30/2015
Give HIV Drugs To Healthy Gay Men, UK Medical Research Council (MRC) Reveals     2/25/2015
Bill Gates Predicts An HIV Vaccine By 2030     1/30/2015
Birth Control Shot Linked To Increased HIV Risk, University of California, Berkeley (CAL) Study     1/12/2015
The Reason Why Experimental HIV Vaccines Backfire, Emory University Study Suggests     1/7/2015
New Technique For Bioengineering Stem Cells Shows Promise In HIV Resistance, University of California, Davis (UCD) Study     1/2/2015
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
University of Oxford Research Suggests Ability Of HIV To Cause AIDS Is Slowing     12/2/2014
2nd Baby Cured Of HIV Relapses, Lancet Reveals     10/3/2014
Teen’s Organs Rejected Because He’s Gay     8/18/2014
Two Cancer Patients "Cured" Of AIDS After Bone Marrow Transplants, St. Vincent Hospital Study     7/21/2014
Joep Lange, The Physician-Scientist Before Medical Diplomat     7/21/2014
Top AIDS Researchers Killed In Malaysia Airlines Crash, Renowned Scientist Joep Lange Among Dead     7/21/2014
AIDS Epidemic May Be Over By 2030 – United Nations Reveals     7/17/2014
Evidence Reveals The Baby That Was "Cured" Of HIV Wasn't     7/11/2014
 More News
Johnson & Johnson (JNJ) Expands IP Policy To Create Broad Access In 128 Countries For Development Of New And Optimized HIV Medicine Formulations For Children Living With HIV     5/11/2015
Mologen AG (MOLGF.PK): Aarhus University Hospital Initiates MGN1703 Study In HIV Patients     5/8/2015
ViiV Healthcare Begins Phase III Programme With dolutegravir/rilpivirine Combination For HIV Maintenance Therapy     5/6/2015
CytoDyn Submits Phase 3 Protocol To FDA After Agreement On Protocol Synopsis     5/4/2015
Mechanism Of Action Of ABIVAX's First-in-class Anti-HIV Drug Published Today In Peer-Reviewed Journal Retrovirology     4/13/2015
NIH Funds Study Of Fully Personalized Immunotherapy AGS-004 Combined With A Latency Reversing Therapy For The Treatment Of HIV     4/1/2015
Argos Therapeutics, Inc. (ARGS) Director Of Immunology To Present At HIV Vaccines Meeting     3/20/2015
Case Western Reserve University Release: Common Herpes Medication Reduces HIV-1 Levels, Independent of Herpes Infection     3/13/2015
HIV-Positive: Is The Treatment Worse Than The Condition, Asks Journal Of American Physicians And Surgeons     3/9/2015
Gilead (GILD) Announces SVR12 Rates From Phase III Study Evaluating Harvoni For The Treatment Of Chronic Hepatitis C In Patients Co-Infected With HIV     2/27/2015
The Black AIDS Institute In Partnership With Novant Health Brings Health Screenings To Black College Students At CIAA     2/27/2015
Bristol-Myers Squibb (BMY) Release: Study Of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results In Preventing Viral Replication Via Different Mechanism Of Action Than Current Therapies     2/26/2015
Sangamo BioSciences (SGMO) Presents New Clinical Data At CROI 2015 From Trial Of ZFP Therapeutic Designed To Provide Functional Control Of HIV     2/26/2015
Bristol-Myers Squibb (BMY) Release: 48-Week Analysis Of Investigational HIV-1 Attachment Inhibitor Paves Way For Phase III Trial Initiation     2/25/2015
BioTime (BTX) Announces First Patient Treated In Pivotal Clinical Trial Of Renevia™ For HIV-Associated Lipoatrophy     2/24/2015